Poddighe D 1
1. Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus: A Systematic Review of the Diagnostic Aspects
2. Fecal and Duodenal Microbiota in Pediatric Celiac Disease
3. Reliability of the Multiplex CytoBead CeliAK Immunoassay to Assess Anti-tTG IgA for Celiac Disease Screening
4. Serum immunoglobulin A (IgA) levels in children affected with Juvenile Idiopathic Arthritis
5. Total serum IgA levels and HLA-DQB1*02:01 allelic status
6. All-cause hospital admissions and incidence of type 2 diabetes among adolescents in Kazakhstan
7. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
8. Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: preliminary clues from a COVID-19 study
9. Prospective and Longitudinal Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Positive and Negative Pneumonia: Potential Role of Decreased Naïve CD8+ in COVID-19 Patients
10. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
11. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
12. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
13. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
14. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
15. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
16. Diagnostic Barriers in Children with Immunodeficiencies in Central Asia: A Case-Based Discussion
17. Analysis of Peripheral Blood Basophils in Pediatric Systemic Lupus Erythematosus
18. Nonspecific increase of αβTCR+ double-negative T cells in pediatric rheumatic diseases
19. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
20. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
21. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
22. The impact of demographics on organ damage in Behçets syndrome: A cross-sectional analysis of the international PROBE cohort
23. Epidemiology of type 1 diabetes mellitus in children in Kazakhstan: Data from unified national electronic health system 2014-2021
24. Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas
25. Association Study of Anticitrullinated Peptide Antibody Status with Clinical Manifestations and SNPs in Patients Affected with Rheumatoid Arthritis: A Pilot Study
26. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
27. Celiac Disease in Uzbek Children: Insights into Disease Prevalence and Clinical Characteristics in Symptomatic Pediatric Patients
28. Case report: Atypical teratoid/rhabdoid tumor of the lateral ventricle in a male adolescent (case-based review and diagnostic challenges in developing countries)
29. Pediatric Extra-Renal Nephroblastoma (Wilms’ Tumor): A Systematic Case-Based Review
30. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
31. Alterations in Gut Microbiota of Infants Born to Mothers with Obesity
32. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014–2021
33. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
34. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
35. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
36. The national and subnational burden of Non-Hodgkin Lymphomas (NHL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023
37. Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations
38. Basophils in autoimmunity: Systemic lupus erythematosus and more?
39. Celiac Disease and Gallbladder: Pathophysiological Aspects and Clinical Issues
40. Celiac Disease in Asia beyond the Middle East and Indian subcontinent: Epidemiological burden and diagnostic barriers
41. Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
42. Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease
43. Double-negative T cells in pediatric rheumatic diseases
44. Double-Negative T (DNT) Cells in Patients with Systemic Lupus Erythematosus
45. Editorial: COVID-19 and hyper inflammation syndrome: Different presentation and management
46. HLA-B*51 allelic and carrier frequency in Kazakhstan: insights into Behçet’s disease prevalence in Central Asia
47. Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
48. Implementing a Pediatric Residency Program in Central Asia in Compliance with ACGME-International Standards: First Experience from Kazakhstan
49. Infantile giant cell hepatitis with autoimmune hemolytic anemia
50. Mycoplasma pneumoniae Infections and Primary Immune Deficiencies
1 2